Advertisement

International Journal of Behavioral Medicine

, Volume 24, Issue 4, pp 563–570 | Cite as

Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms

  • Vera AlmeidaEmail author
  • Sofia Taveira
  • Maribel Teixeira
  • Isabel Almeida
  • José Rocha
  • Ana Teixeira
Article

Abstract

Purpose

There are known connections between emotions and psoriasis; however, we have not established a clear pathway for this association. This study aimed to explore correlates of difficulties in emotional regulation in patients with psoriasis and predict the influence of emotional regulation in psoriasis disability.

Method

Two hundred and twenty eight participants completed the Difficulties in Emotion Regulation Scale, Self-administered Psoriasis Area and Severity Index, Psoriasis Disability Index, and Brief Symptom Inventory. Spearman’s correlation and a hierarchical stepwise multiple regression were carried out to analyse associations.

Results

Results indicated that patients with the most recent diagnoses experienced greater difficulty in acting in accordance with goals (r = .16, p < .05) but lesser difficulty in engaging in goal-directed behaviour (r = −.15, p < .05). Those with greater satisfaction with treatment exhibited fewer difficulties in emotional regulation (r = −.23, p < .01). The patients who experienced greater difficulty in emotional regulation perceived greater psoriasis severity (r = .15, p < .05) and disability (r = .36, p < .05), reported more psychopathological symptoms (correlations between .46 and .56), and missed work/school more frequently (r = .24, p < .05). Impulse control proved to be the strongest predictor to psoriasis disability (β = .34).

Conclusion

The results highlighted the relationship between emotional regulation difficulty, disease characteristics, and psychological variables in psoriasis disability emphasizing the importance of including a broader approach in clinical management of psoriatic patients.

Keywords

Psoriasis Emotional regulation Psychopathological symptoms Psoriasis disability 

Notes

Acknowledgments

The authors would like to thank CESPU [project 04-GCQF-CICS-2011N] for their financial support, all patients who participated in the study, and the Portuguese Association of Psoriasis (PSOPortugal) for assistance with data collection.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit KH. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60(3):394–401. doi: 10.1016/j.jaad.2008.10.062.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Branco M, Nogueira P, Conteiras T. Uma observação sobre a prevalência de algumas doenças crónicas em Portugal Continental. In: Saúde Md, editor. Lisboa: Observatório Nacional de Saúde. 2005Google Scholar
  3. 3.
    Galadari I, Sharif MO, Galadari H. Psoriasis: a fresh look. Clin Dermatol. 2005;23(5):491–502. doi: 10.1016/j.clindermatol.2005.01.009.CrossRefPubMedGoogle Scholar
  4. 4.
    Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol. 2005;152(5):861–7. doi: 10.1111/j.1365-2133.2005.06502.x.CrossRefPubMedGoogle Scholar
  5. 5.
    Gupta MA, Gupta AK. Current concepts in psychodermatology. Current Psychiatry Reports. 2014;16(6):449. doi: 10.1007/s11920-014-0449-9.CrossRefPubMedGoogle Scholar
  6. 6.
    Madhulika A, Gupta M. Psychodermatology. Psychiatric Times. 2006;23:78–89.Google Scholar
  7. 7.
    Janković S, Raznatović M, Marinkovic J, Maksimović N, Janković J, Djikanović B. Relevance of psychosomatic factors in psoriasis: a case-control study. Acta Derm Venereol. 2009;89(4):364–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Mazzetti M, Mozzetta A, Soavi GC, et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol Suppl. 1994;186:62–4.Google Scholar
  9. 9.
    Zachariae R, Zachariae H, Blomqvist K, et al. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol. 2004;18(1):27–36.CrossRefPubMedGoogle Scholar
  10. 10.
    Griffiths CEM, Richards HL. Psychological influences in psoriasis. Clin Exp Dermatol. 2001;26(4):338–42. doi: 10.1046/j.1365-2230.2001.00834.x.CrossRefPubMedGoogle Scholar
  11. 11.
    Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54–9. doi: 10.1111/j.1529-8019.2008.00170.x.CrossRefPubMedGoogle Scholar
  12. 12.
    Hrehorów E, Salomon J, Matusiak L, Reich A, Szepietowski C. Patients with psoriasis feel stigmatized. Acta Dermato Venereologica. 2011;91:1–6.Google Scholar
  13. 13.
    Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124(7):1052–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Bhosle M, Kulkarni A, Feldman S, Balkrishnan R. Quality of life in patients with psoriasis. Health and Quality of Life Outcomes. 2006;4(1):35.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fernandes BC. Qualidade de vida nos doentes com psoríase—Criação da versão Portuguesa do Psoriasis Disability Index. Coimbra: University of Coimbra; 2010.Google Scholar
  16. 16.
    Richards HL, Fortune DG, Griffiths CEM, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50(1):11–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Leibovici V, Canetti L, Yahalomi S, et al. Well being, psychopathology and coping strategies in psoriasis compared with atopic dermatitis: a controlled study. J Eur Acad Dermatol Venereol. 2010;24(8):897–903. doi: 10.1111/j.1468-3083.2009.03542.x.CrossRefPubMedGoogle Scholar
  18. 18.
    Russo PAJ, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol. 2004;45(3):155–61. doi: 10.1111/j.1440-0960.2004.00078.x.CrossRefPubMedGoogle Scholar
  19. 19.
    Mota SMC, Gon CCM, Gon SA. Análise comportamental de Problemas de Interação Social de Individuos com Psoríase. Interação em Psicologia. 2009;13(1):155–64.CrossRefGoogle Scholar
  20. 20.
    Reich K, Nestle FO, Wu Y, et al. Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis. Eur J Dermatol. 2007;17(5):381–6.PubMedGoogle Scholar
  21. 21.
    Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846–50. doi: 10.1046/j.1365-2133.1998.02511.x.CrossRefPubMedGoogle Scholar
  22. 22.
    Rapp SR, Exum ML, Reboussin DM, Feldman SR, Fleischer A, Clark A. The physical, psychological and social impact of psoriasis. J Health Psychol. 1997;2(4):525–37. doi: 10.1177/135910539700200409.CrossRefPubMedGoogle Scholar
  23. 23.
    Gross JJ. Emotion regulation: affective, cognitive, and social consequences. Psychophysiology. 2002;39(3):281–91. doi: 10.1017/s0048577201393198.CrossRefPubMedGoogle Scholar
  24. 24.
    Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004;26(1):41–54.CrossRefGoogle Scholar
  25. 25.
    Barankin B, DeKoven J. Psychosocial effect of common skin diseases. Can Fam Physician. 2002;48:712–6.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Fry L. An atlas of psoriasis. 2nd ed. London: Taylor & Francis Group; 2004.Google Scholar
  27. 27.
    Ramsay B, O’Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol. 1988;118(2):195–201. doi: 10.1111/j.1365-2133.1988.tb01774.x.CrossRefPubMedGoogle Scholar
  28. 28.
    Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147(4):736–42.CrossRefPubMedGoogle Scholar
  29. 29.
    Chisholm A, Nelson PA, Pearce CJ, et al. The role of personal models in clinical management: exploring health care providers’ beliefs about psoriasis. Br J Health Psychol. 2016;21(1):114–34. doi: 10.1111/bjhp.12148.CrossRefPubMedGoogle Scholar
  30. 30.
    de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Allegranti I, Gon T, Magatonrizzi G, Aguglia E. Prevalence of alexithymic characteristics in psoriatic patients. Acta Derm Venereol. 1994;74:146–7.Google Scholar
  32. 32.
    Mingnorance R, Loureiro S, Okino L, Foss N. Pacientes com psoríase: adaptação psicossocial e características de personalidade. Medicina. 2001;34:315–24.Google Scholar
  33. 33.
    Bahmer JA, Kuhl J, Bahmer FA. How do personality systems interact in patients with psoriasis, atopic dermatitis and urticaria? Acta Derm Venereol. 2007;87(4):317–24.CrossRefPubMedGoogle Scholar
  34. 34.
    Schmutz JL. How to evaluate the severity of psoriasis? Ann Dermatol Venereol. 2003;130(8–9 Pt 2):843–6.PubMedGoogle Scholar
  35. 35.
    Feldman SR, Fleischer Jr AB, Reboussin DM, et al. The self-administered psoriasis area and severity index is valid and reliable. The Journal Of Investigative Dermatology. 1996;106(1):183–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol. 1990;123(6):751–6. doi: 10.1111/j.1365-2133.1990.tb04192.x.CrossRefPubMedGoogle Scholar
  37. 37.
    Simões M, Machado C, Gonçalves M, Almeida L. Avaliação psicológica: Instrumentos validados para a população portuguesa. Coimbra: Quarteto; 2007.Google Scholar
  38. 38.
    Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CEM. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol. 2001;45(1):72–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol. 1993;32(8):587–91.CrossRefPubMedGoogle Scholar
  40. 40.
    Devrimci-Ozguven H, Kundakci N, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14(4):267–71. doi: 10.1046/j.1468-3083.2000.00085.x.CrossRefPubMedGoogle Scholar
  41. 41.
    Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology. 2006;212(2):123–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Aghaei S, Ardekani GS. Impact of psoriasis on quality of life in Iran. J Eur Acad Dermatol Venereol. 2007;21:32–3.Google Scholar
  43. 43.
    Castro SI, Rocha JC. The moderating effects of previous losses and emotional clarity on bereavement outcome. Journal of Loss and Trauma. 2012;18(3):248–59. doi: 10.1080/15325024.2012.687327.CrossRefGoogle Scholar
  44. 44.
    Coutinho J, Ribeiro E, Ferreirinha R, Dias P. The Portuguese version of the difficulties in emotion regulation scale and its relationship with psychopathological symptoms. Rev Psiquiatr Clín. 2009;37(4):145–51.CrossRefGoogle Scholar
  45. 45.
    Finlay AY, Coles EC. The effect of severe psoriasis on the quality-of-life of 369 patients. Br J Dermatol. 1995;132(2):236–44.CrossRefPubMedGoogle Scholar
  46. 46.
    DeWeerdt S. Psychodermatology: an emotional response. Nature. 2012;492(7429):S62–S3.CrossRefPubMedGoogle Scholar
  47. 47.
    Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol. 2002;41(Pt 2):157–74.CrossRefPubMedGoogle Scholar
  48. 48.
    Paradisi A, Abeni D, Finore E, et al. Effect of written emotional disclosure interventions in persons with psoriasis undergoing narrow band ultraviolet B phototherapy. Eur J Dermatol. 2010;20(5):599–605.PubMedGoogle Scholar
  49. 49.
    Fordham B, Griffiths CE, Bundy C. A pilot study examining mindfulness-based cognitive therapy in psoriasis. Psychol Health Med. 2015;20(1):121–7. doi: 10.1080/13548506.2014.902483.CrossRefPubMedGoogle Scholar
  50. 50.
    Schut C, Muhl S, Reinisch K, et al. Agreeableness and self-consciousness as predictors of induced scratching and itch in patients with psoriasis. Int J Behav Med. 2015;22(6):726–34. doi: 10.1007/s12529-015-9471-5.CrossRefPubMedGoogle Scholar
  51. 51.
    Chambers R, Gullone E, Allen NB. Mindful emotion regulation: an integrative review. Clin Psychol Rev. 2009;29(6):560–72. doi: 10.1016/j.cpr.2009.06.005.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Behavioral Medicine 2016

Authors and Affiliations

  • Vera Almeida
    • 2
    Email author
  • Sofia Taveira
    • 1
  • Maribel Teixeira
    • 2
  • Isabel Almeida
    • 2
  • José Rocha
    • 1
  • Ana Teixeira
    • 1
    • 2
  1. 1.CESPU Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da SaúdeRua Central de GandraGandraPortugal
  2. 2.UCIBIO, REQUIMTE, Laboratório de Tecnologia Farmacêutica, Faculdade de FarmáciaUniversidade do PortoPortoPortugal

Personalised recommendations